Loading...
The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
BACKGROUND. Assessment of donor-specific cell-free DNA (dscfDNA) in the recipient is emerging as a noninvasive biomarker of organ rejection after transplantation. We previously developed a digital polymerase chain reaction (PCR)-based approach that readily measures dscfDNA within clinically relevant...
Na minha lista:
| Udgivet i: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6616138/ https://ncbi.nlm.nih.gov/pubmed/31334336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000902 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|